肿瘤的免疫细胞治疗
Immunocellular Therapy of Tumor
呼吸系统疾病特别是肺纤维化的免疫调控机制研究及干细胞治疗
Immune regulation mechanism of respiratory diseases, especially pulmonary fibrosis and stem cell therapy
美高梅附属东方医院大内科教秘
Secretary of Internal Medicine Department Faculty Working Office, East Hospital, Tongji University School of Medicine
中华医学会呼吸病学分会肺癌学组青年协作组委员
Youth Federation Member of Chinese Thoracic Society Lung Cancer Group
中国抗癌协会会员
Member of China Anti Cancer Association
北京大学医学博士，现任美高梅附属东方医院大内科教秘，呼吸医学中心、肺癌中心主治医师，曾荣获国家“优秀志愿者”称号、青年志愿者铜奖奖章及2021东方医院“东方人物”等荣誉。
研究方向主要聚焦肿瘤的免疫治疗，慢性气道疾病的免疫机制及干细胞治疗。主持在研国家自然科学基金面上项目1项，主导完成及参与国家及北京市自然基金、北京科委专项、北京大学临床X专项、上海科创基金项目、免疫学国家重点实验室开放课题等各类基金6项，于Molecular Therapy、Acta Biomaterialia、ACS Applied Bio Materials、Autophagy等期刊主导及参与发表论文10余篇。主导及参与在研“肺癌介入免疫治疗”、“新型T细胞治疗肿瘤”、“纤维化肺疾病干细胞治疗”等临床试验多项。
欢迎国内外感兴趣的同学一起参与以上科学问题的探索研究，我们将根据不同的课题，选择与北京大学等一流的研究平台合作，共同进步！最后，再次感谢有缘人的关注，谢谢！
I graduated from Peking University with a doctor's degree. Now I am the secretary of the Department of Internal Medicine of the East Hospital, Tongji University School of Medicine, and the attending physician of the Respiratory Medical Center and Lung Cancer Center. I have won the national title of "Excellent Volunteer", the Bronze Medal for Young Volunteers, and the 2021 "Oriental Person" and other honors.
Our research direction mainly focuses on tumor immunotherapy, immune mechanism of chronic airway disease and stem cell therapy.I am researching one general project of the National Natural Science Foundation of China, and has led and participated in six kinds of funds, including the National and Beijing Natural Science Foundation of China, the Beijing Science Commission Special Project, the Peking University Clinical X Special Project, the Shanghai Science and Innovation Fund Project, and the Open Topics of the National Key Laboratory of Immunology.I have led and participated in publishing more than 10 papers in Molecular Therapy, Acta Biomaterials, ACS Applied Bio Materials, Autophagy and other journals.And has led and participated in many clinical trials such as "interventional immunotherapy for lung cancer", "novel T cell therapy for cancer", and "stem cell therapy for pulmonary fibrosis".
Welcome interested students at home and abroad to participate in the exploration and research of the above related scientific issues. We will cooperate with Peking University and other first-class research platforms according to different topics to make common progress! Finally, thank you for your attention. Thank you!
